Tag: rebound

Airlines ETF & Stocks Ride the Rebound in Travel Demand

The coronavirus outbreak has hammered the U.S. economy, with the airline sector being one of the worst-hit spaces. The virus’ spread resulted in declining air travel with restrictions imposed by the government. Consequently, airlines’ top lines suffered a material impact as passenger revenues form the largest component of their total revenue base. However, it seems like the worst is over for the airline industry as the United States has started to reopen its economy with permission for inter-state travel.

In fact, airlines in many parts of the world are planning to resume flights starting this month as economies are reopening

Read more

Cerner (CERN) Down 3.8% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Cerner (CERN). Shares have lost about 3.8% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Cerner due for a breakout? Before we dive into how investors and analysts have reacted as of late, let’s take a quick look at the most recent earnings report in order to get a better handle on the important drivers.

Cerner Q1 Earnings Beat Estimates, Revenues Miss

Cerner Corporation reported first-quarter 2020 adjusted earnings of 71 cents per share,

Read more

Expedia signals May rebound as cancellations stabilize

By Sanjana Shivdas

(Reuters) – Online travel booking company Expedia Group Inc <EXPE.O> on Wednesday pointed to demand recovering in May as cancellation rates stabilize, overshadowing a bigger-than-expected quarterly loss and sending its shares up nearly 4%.

U.S. airlines have signaled slower ticket cancellations and an improvement in bookings on some routes, as countries ease lockdowns imposed to curb the spread of the coronavirus that had crippled the global travel industry.

“What we’ve seen is green shoots in the areas you would expect, places where movement has become possible, where people can now start to think about their summer holiday,”

Read more

Stocks rebound Monday as Moderna’s coronavirus vaccine trial boosts optimism for economy

Stocks rebounded Monday from losses last week on optimism that the U.S. economy might start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine. 

The Dow Jones industrial average soared 912 points to close at 24,597. The S&P 500 jumped 3.2%, erasing its losses from last week.

Shares of Moderna surged 20% after the biotechnology company reported encouraging phase one results for a potential COVID-19 vaccine in a small early stage clinical trial. It showed the production of antibodies to the virus in all of its 45 trial participants, Moderna said, a positive

Read more